Author:
Federico Leonardo Bruno,Barcelos Mariana Pegrucci,Silva Gulherme Martins,Francischini Isaque Antonio Galindo,Taft Carlton A.,da Silva Carlos Henrique Tomich de Paula
Publisher
Springer International Publishing
Reference189 articles.
1. Office, U. S. G. A. Drug Industry: Profits, Research and Development Spending, and Merger and Acquisition Deals. (2017)
2. Ledley, F.D., McCoy, S.S., Vaughan, G., Cleary, E.G.: Profitability of large pharmaceutical companies compared with other large public companies. JAMA-J. Am. Med. Assoc. 323, 834–843 (2020)
3. Tay-Teo, K., Ilbawi, A., Hill, S.R.: Comparison of sales income and research and development costs for FDA-approved cancer drugs sold by originator drug companies. JAMA Netw. Open 2, e186875 (2019)
4. DiMasi, J.A., Grabowski, H.G., Hansen, R.W.: Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20–33 (2016)
5. Costantini, S., Walensky, R.P.: The costs of drugs in infectious diseases: branded, generics, and why we should care. J. Infect. Dis. 221, (2019)
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献